HAO did a 1-for-20 reverse split on Aug 14, 2026. Fund positions use its last close before the split, $1.81 on Nov 12, 2026, until the new shares are matched.
Haoxi Health Technology Limited
HAO institutional ownership changes in Q3 2026: 2 institutions opened or added positions, 0 trimmed or exited. HAO (Haoxi Health Technology Limited) is held by 2 institutional investors as of Q3 2026. Top institutional shareholders: UBS Group AG ($8,911), JPMorgan Chase & Co. ($6). Institutions were buying, on balance.
Who's Trading
Source dates: Price Nov 13, 2026 · Insiders none · Activists none · Congress none
No recent insider, activist, or congressional trades for HAO.
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
New | 3,264 | $8,911 | 0.0% | -33.70% | 26 | |
New | 2 | $6 | 0.0% | -33.70% | 17 |
HAOHaoxi Health Technology LimitedContinue exploring
Questions investors ask about HAO
Who owns HAO?
2 institutional investors held HAO on September 30, 2026, led by UBS Group AG ($8,911) and JPMorgan Chase & Co. ($6).
How many hedge funds hold HAO?
2 institutional investors reported HAO in their 13F filings for the quarter ended September 30, 2026, $8,917 in all.
Are institutions buying or selling HAO?
Buying, on balance. In Q3 2026, 2 institutions opened or added to positions in HAO and 0 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer